Financials
Financial year 2025
Dr. C. Cornelissen Intensieve Geneeskunde from Bertem, company number BE0765675042, closed financial year 2025 with a result of € 148,390 after tax. For that financial year Dr. C. Cornelissen Intensieve Geneeskunde recorded a gross margin of € 204,069 and equity of € 2,000. Compared with financial year 2024, the result moved from € 108,171 to € 148,390. Profitable, and profit is growing. The buffer shrank hard: equity is 99 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 26, 2026.
€ 2,000
▼ 99% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 148,390
▲ 37% vs 2024
Profit after tax over the fiscal year.
€ 156,849
▲ 11% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 355,066 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 10,680
▼ 5% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,272
▼ 75% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 55,550
▲ 153% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 58,803 | € 73,543 | € 147,009 | € 204,069 | ▲ 39% |
| Profit after taxes | € 43,829 | € 55,007 | € 108,171 | € 148,390 | ▲ 37% |
| Equity | € 45,498 | € 100,505 | € 208,676 | € 2,000 | ▼ 99% |
| Total debts | € 34,677 | € 23,615 | € 34,898 | € 194,929 | ▲ € 160,031 |
| Cash | € 74,108 | € 104,649 | € 141,835 | € 156,849 | ▲ 11% |
| Retained profit | € 43,498 | € 98,505 | € 206,676 | € 0 | ▼ 100% |
| Dividend | € 0 | € 0 | € 0 | € 355,066 | |
| Balance sheet total | € 80,175 | € 124,120 | € 243,574 | € 196,929 | ▼ 19% |
Key figures of Dr. C. Cornelissen Intensieve Geneeskunde, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Dr. C. Cornelissen Intensieve Geneeskunde?
What happened at Dr. C. Cornelissen Intensieve Geneeskunde in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 148,390 (▲ 37% vs 2024). filed late Source: NBB ↗
- New establishment in Leuven. KBO
- Start of the company according to the CBE. KBO
In short
From € 43,829 profit in 2022 to € 148,390 profit in 2025.
Paid € 108,853 in corporate taxes since 2022.
Best year ever: 2025, with € 148,390 profit.
Paid out € 355,066 in dividends to the owners in total.
A new publication or filing at Dr. C. Cornelissen Intensieve Geneeskunde? We notify you, reason included.
Follow Dr. C. Cornelissen Intensieve GeneeskundeDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Dr. C. Cornelissen Intensieve Geneeskunde is Cathelle Cornelissen.
Directors
According to the 2025 annual accounts
Cathelle Cornelissen
Director
Establishments
Establishment units
Physical locations of this company
Dorpstraat 625
3061 Bertem
Stadsvest 43
3012 Leuven
Active since 25 March 2021
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0765.675.042
- VAT number
- BE 0765.675.042
- Registered office
- Dorpstraat 625, 3061 Bertem
- Names & denominations
- Dr. C. Cornelissen Intensieve Geneeskunde
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 25 March 2021
- Peppol
- Active · Active since 18 Dec 2024
- Activities · NACE
Activiteiten van medisch specialisten
Activiteiten van huisartspraktijken